Close menu




November 1st, 2021 | 13:56 CET

wallstreet:online, Deutsche Bank, GFT Technologies - It should continue to improve here!

  • Investments
Photo credits: pixabay.com

Low-interest rates, high inflation and economic growth, form the framework conditions that continue to speak for a positive stock market environment and rising share prices. The three following companies benefit from this in different ways and should also perform well in the coming year. Who is your favorite?

time to read: 3 minutes | Author: Carsten Mainitz
ISIN: WALLSTREET:ONLINE INH ON | DE000A2GS609 , DEUTSCHE BANK AG NA O.N. | DE0005140008 , GFT TECHNOLOGIES SE | DE0005800601

Table of contents:


    wallstreet:online - Analysts: Almost 80% upside potential available!

    The Company is the largest independent operator of wide-ranging stock market portals in the German-speaking world. With the launch of the neobroker Smartbroker, the Group completed an important step at the end of 2019. The transaction business now shapes the Company's equity story. The central task is to better integrate the financial offerings of Smartbroker into the stock market portals and thus leverage synergies and accelerate growth. The trading front end is to be completely revamped, and a Smartbroker app developed. At the end of the first half of the year, the Group had more than 187,000 securities accounts, of which more than 142,000 were Smartbroker customers, with assets under management of EUR 6.8 billion.

    Smartbroker expanded its management team in recent months with high-caliber industry experts to support its dynamic growth and achieve its set goals. In addition, an application for the extension of the existing KWG license was submitted in the summer. Smartbroker differentiates itself in terms of the broad field of neobrokers, which offer investors, among other things, free stock trading by providing low conditions and additionally a wide range of products. The interlocking with the stock exchange portals should make the share certificates the winners on the German share price list.

    The analysts of GBC still trust the share. The experts combine their buy recommendation with a price target of EUR 37.70. That is an upside potential of almost 80%. The Berlin-based Company had confirmed its guidance for the current fiscal year in the context of its half-year figures. Accordingly, the Management Board continues to expect an increase in sales to around EUR 45 to 50 million and an increase in operating earnings (EBITDA) to EUR 4 to 6 million.

    Deutsche Bank - Profit-taking after good figures

    Last week, the listed German industry leader presented its figures for the third quarter. The data turned out better than analysts expected. For the fifth quarter in a row, the Frankfurt-based bank was now able to report a profit. Investors nevertheless took profits. The share price is currently just above the EUR 11 mark, giving the Group a market capitalization of EUR 23 billion. The shares are still trading at a significant discount to the tangible book value per share, which according to the balance sheet, stands at EUR 24.46. The share price is still at a high level.

    Rising sales and falling risk provisions led to profit growth in Q3 and the first nine months. Overall, the financial institution is making good progress with branch closures and job cuts, so meeting the communicated targets seems realistic. In the third quarter, the bank earned around EUR 0.6 billion before taxes; in the first nine months, the figure was as high as EUR 1.8 billion, compared with just EUR 0.1 billion in the previous year. For the current fiscal year, the 28 analysts currently covering the stock expect EPS of EUR 0.70, rising to EUR 1.27 in 2022. The dividend is also expected to increase from EUR 0.25 to EUR 0.36. Overall, the stock is attractively valued.

    GFT Technologies - Another forecast increase

    Last week, the specialist for the digital transformation of leading global companies in the finance, insurance and industrial sectors once again raised its forecast for the current year due to a significant increase in client demand. The Company now expects revenue of EUR 560 million (previously: EUR 550 million) and also holds out the prospect of a 20% increase in revenue for 2022. Operating profit is expected to grow disproportionately this year and next. For 2021, the benchmark is adjusted EBITDA of EUR 65 million (previously EUR 62 million) and profit before tax of EUR 40 million (previously EUR 36 million).

    On the one hand, the market is growing for the solutions of the IT service provider and software developer, which offers in-depth consulting and development around forward-looking technologies - from cloud engineering to artificial intelligence and mainframe modernization to the Internet of Things for Industry 4.0. On the other hand, catch-up effects are now also occurring. Customers had cut their budgets recently. In terms of the chart, the share recently achieved significant success with the leap above EUR 40. The stock also has additional room for improvement in terms of valuation.


    All the lights are green. The underlying conditions and the individual situation of the three companies described here suggest that share prices will continue to rise. In our opinion, the shares of wallstreet:online have a lot of potential. GBC analysts believe that the share has a potential of almost 80%. Looking at the Company valuation and prospects of Deutsche Bank and GFT, the shares are by no means overvalued.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Stefan Feulner on October 4th, 2022 | 11:59 CEST

    RWE, Pathfinder Ventures, United Internet - Panic as an opportunity

    • Camping
    • Investments

    Last week, the crash prophets crawled out of their caves and outdid themselves with forecasts reaching the Corona lows at around 8,000 points in the leading German DAX index. Without a doubt, the general conditions for a sustained stock rally are moderate with the escalation of the Ukraine situation and concerns about further interest rate hikes. Nevertheless, there are attractive entry opportunities at the current level, which could pay off in cash in the long term.

    Read

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read